241 related articles for article (PubMed ID: 19221211)
1. Atorvastatin restores endothelial function in offspring of protein-restricted rats in a cholesterol-independent manner.
Torrens C; Kelsall CJ; Hopkins LA; Anthony FW; Curzen NP; Hanson MA
Hypertension; 2009 Apr; 53(4):661-7. PubMed ID: 19221211
[TBL] [Abstract][Full Text] [Related]
2. Long-term atorvastatin improves age-related endothelial dysfunction by ameliorating oxidative stress and normalizing eNOS/iNOS imbalance in rat aorta.
Gong X; Ma Y; Ruan Y; Fu G; Wu S
Exp Gerontol; 2014 Apr; 52():9-17. PubMed ID: 24463049
[TBL] [Abstract][Full Text] [Related]
3. Atorvastatin restores endothelial function in normocholesterolemic smokers independent of changes in low-density lipoprotein.
Beckman JA; Liao JK; Hurley S; Garrett LA; Chui D; Mitra D; Creager MA
Circ Res; 2004 Jul; 95(2):217-23. PubMed ID: 15178637
[TBL] [Abstract][Full Text] [Related]
4. Atorvastatin restores the impaired vascular endothelium-dependent relaxations mediated by nitric oxide and endothelium-derived hyperpolarizing factors but not hypotension in sepsis.
Subramani J; Kathirvel K; Leo MD; Kuntamallappanavar G; Uttam Singh T; Mishra SK
J Cardiovasc Pharmacol; 2009 Dec; 54(6):526-34. PubMed ID: 19755915
[TBL] [Abstract][Full Text] [Related]
5. Atorvastatin prevents end-organ injury in salt-sensitive hypertension: role of eNOS and oxidant stress.
Zhou MS; Jaimes EA; Raij L
Hypertension; 2004 Aug; 44(2):186-90. PubMed ID: 15238570
[TBL] [Abstract][Full Text] [Related]
6. Atorvastatin prevents angiotensin II-induced vascular remodeling and oxidative stress.
Briones AM; Rodríguez-Criado N; Hernanz R; García-Redondo AB; Rodrigues-Díez RR; Alonso MJ; Egido J; Ruiz-Ortega M; Salaices M
Hypertension; 2009 Jul; 54(1):142-9. PubMed ID: 19451411
[TBL] [Abstract][Full Text] [Related]
7. Atorvastatin restores arsenic-induced vascular dysfunction in rats: modulation of nitric oxide signaling and inflammatory mediators.
Kesavan M; Sarath TS; Kannan K; Suresh S; Gupta P; Vijayakaran K; Sankar P; Kurade NP; Mishra SK; Sarkar SN
Toxicol Appl Pharmacol; 2014 Oct; 280(1):107-16. PubMed ID: 25058445
[TBL] [Abstract][Full Text] [Related]
8. Atorvastatin protects obese mice against hepatic ischemia-reperfusion injury by Toll-like receptor-4 suppression and endothelial nitric oxide synthase activation.
Ajamieh H; Farrell G; Wong HJ; Yu J; Chu E; Chen J; Teoh N
J Gastroenterol Hepatol; 2012 Aug; 27(8):1353-61. PubMed ID: 22432744
[TBL] [Abstract][Full Text] [Related]
9. HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species.
Wassmann S; Laufs U; Bäumer AT; Müller K; Ahlbory K; Linz W; Itter G; Rösen R; Böhm M; Nickenig G
Hypertension; 2001 Jun; 37(6):1450-7. PubMed ID: 11408394
[TBL] [Abstract][Full Text] [Related]
10. Rapid, direct effects of statin treatment on arterial redox state and nitric oxide bioavailability in human atherosclerosis via tetrahydrobiopterin-mediated endothelial nitric oxide synthase coupling.
Antoniades C; Bakogiannis C; Leeson P; Guzik TJ; Zhang MH; Tousoulis D; Antonopoulos AS; Demosthenous M; Marinou K; Hale A; Paschalis A; Psarros C; Triantafyllou C; Bendall J; Casadei B; Stefanadis C; Channon KM
Circulation; 2011 Jul; 124(3):335-45. PubMed ID: 21730307
[TBL] [Abstract][Full Text] [Related]
11. The protective effect of HMG-CoA reductase inhibitors against monocrotaline-induced pulmonary hypertension in the rat might not be a class effect: comparison of pravastatin and atorvastatin.
Rakotoniaina Z; Guerard P; Lirussi F; Goirand F; Rochette L; Dumas M; Bardou M
Naunyn Schmiedebergs Arch Pharmacol; 2006 Dec; 374(3):195-206. PubMed ID: 17102939
[TBL] [Abstract][Full Text] [Related]
12. Effect of raloxifene and atorvastatin in atherosclerotic process in ovariectomized rats.
Cetinkaya Demir B; Uyar Y; Ozbilgin K; Köse C
J Obstet Gynaecol Res; 2013 Jan; 39(1):229-36. PubMed ID: 22845341
[TBL] [Abstract][Full Text] [Related]
13. Synergism between melatonin and atorvastatin against endothelial cell damage induced by lipopolysaccharide.
Dayoub JC; Ortiz F; López LC; Venegas C; Del Pino-Zumaquero A; Roda O; Sánchez-Montesinos I; Acuña-Castroviejo D; Escames G
J Pineal Res; 2011 Oct; 51(3):324-30. PubMed ID: 21585521
[TBL] [Abstract][Full Text] [Related]
14. Effects of atorvastatin, amlodipine, and their combination on vascular dysfunction in insulin-resistant rats.
Okamura T; Tawa M; Geddawy A; Shimosato T; Iwasaki H; Shintaku H; Yoshida Y; Masada M; Shinozaki K; Imamura T
J Pharmacol Sci; 2014; 124(1):76-85. PubMed ID: 24389820
[TBL] [Abstract][Full Text] [Related]
15. Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation.
Wagner AH; Köhler T; Rückschloss U; Just I; Hecker M
Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):61-9. PubMed ID: 10634801
[TBL] [Abstract][Full Text] [Related]
16. Atorvastatin prevents endothelial dysfunction in mesenteric arteries from spontaneously hypertensive rats: role of cyclooxygenase 2-derived contracting prostanoids.
Virdis A; Colucci R; Versari D; Ghisu N; Fornai M; Antonioli L; Duranti E; Daghini E; Giannarelli C; Blandizzi C; Taddei S; Del Tacca M
Hypertension; 2009 Jun; 53(6):1008-16. PubMed ID: 19380610
[TBL] [Abstract][Full Text] [Related]
17. Withdrawal of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors elicits oxidative stress and induces endothelial dysfunction in mice.
Vecchione C; Brandes RP
Circ Res; 2002 Jul; 91(2):173-9. PubMed ID: 12142351
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory stress induces statin resistance by disrupting 3-hydroxy-3-methylglutaryl-CoA reductase feedback regulation.
Chen Y; Ku H; Zhao L; Wheeler DC; Li LC; Li Q; Varghese Z; Moorhead JF; Powis SH; Huang A; Ruan XZ
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):365-76. PubMed ID: 24233489
[TBL] [Abstract][Full Text] [Related]
19. Statins reverse renal inflammation and endothelial dysfunction induced by chronic high salt intake.
Fiore MC; Jimenez PM; Cremonezzi D; Juncos LI; García NH
Am J Physiol Renal Physiol; 2011 Aug; 301(2):F263-70. PubMed ID: 21543414
[TBL] [Abstract][Full Text] [Related]
20. Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells.
Hernández-Perera O; Pérez-Sala D; Navarro-Antolín J; Sánchez-Pascuala R; Hernández G; Díaz C; Lamas S
J Clin Invest; 1998 Jun; 101(12):2711-9. PubMed ID: 9637705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
